| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Revenue | ||||||
15,983 | 14,414 | 3,893 | 1,092 | 152 | - | - |
Operating expenses: | ||||||
Research and development | ||||||
175,431 | 134,428 | 79,309 | 40,818 | 9,057 | 2,395 | 1,920 |
General and administrative | ||||||
48,869 | 39,509 | 26,975 | 15,994 | 10,393 | 2,999 | 1,654 |
Total operating expenses | ||||||
224,300 | 173,937 | 106,284 | 56,812 | 19,450 | 5,394 | 3,574 |
Loss from operations | ||||||
-208,317 | -159,523 | -102,391 | -55,720 | -19,298 | -5,394 | -3,574 |
Other income, net: | ||||||
Dividend income | ||||||
4,912 | 3,368 | 1,578 | 255 | - | - | - |
Interest income, net | ||||||
29 | 22 | 6 | 337 | 86 | -12 | -111 |
Other income (expense), net | ||||||
9,738 | 9,549 | -331 | -50 | 56 | 261 | 37 |
Total other income, net | ||||||
14,679 | 12,939 | 1,253 | 542 | 142 | 249 | -74 |
Loss before income taxes | ||||||
-193,638 | -146,584 | -101,138 | -55,178 | -19,156 | -5,145 | -3,648 |
Income tax provision | ||||||
0 | 69 | 842 | 482 | 44 | 84 | -330 |
Net loss | ||||||
-193,638 | -146,653 | -101,980 | -55,660 | -19,200 | -5,229 | -3,318 |
Net loss per share attributable to ordinary shareholders—basic and diluted | ||||||
-5.72 | -5.06 | -3.85 | -2.44 | -1.83 | -1.34 | -1.90 |
Weighted-average ordinary shares used in computing net loss per share attributable to ordinary shareholders—basic and diluted | ||||||
33,866 | 28,970 | 26,513 | 22,800 | 10,501 | 3,911 | 1,743 |
Other comprehensive income (loss): | ||||||
Net loss | ||||||
-193,638 | -146,653 | -101,980 | -55,660 | - | - | - |
Foreign currency translation | ||||||
114 | 37 | 407 | -332 | - | - | - |
Comprehensive loss | ||||||
-193,524 | -146,616 | -101,573 | -55,992 | - | - | - |